Sec. 10. Exemption.

330 words·~2 min read·/il/chapter-410/act-51/10

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Sec. 10. Exemption. The Department of Public Health may exempt the use of a vaccine from this Act if the Department finds that an actual or potential bio-terrorist incident or other actual or potential public health emergency, including an epidemic or shortage of supply of a vaccine at a reasonable cost that would prevent a person from receiving the needed vaccine, makes necessary the administration of a vaccine containing more mercury than the maximum level set forth in subsection

(a)or subsection

(b)of Section 5 in the case of influenza vaccine. The exemption shall meet all of the following conditions:

(1)The exemption shall not be issued for more than 12 months.

(2)At the end of the effective period of any exemption, the Department may issue

another exemption for up to 12 months for the same incident or public health emergency, if the Department makes a determination that any exemption is necessary as set forth in this Section and the Department notifies the legislature and interested parties pursuant to paragraphs (3), (4), and (5).

(3)Upon issuing an exemption, the Department shall, within 48 hours, notify the

legislature about any exemption and about the Department's findings justifying the exemption's approval.

(4)Upon request for an exemption, the Department shall notify an interested party, who

has expressed his or her interest to the Department in writing, that an exemption request has been made.

(5)Upon issuing an exemption, the Department shall, within 7 days, notify an interested

party, who has expressed his or her interest to the Department in writing, about any exemption and about the Department's findings justifying the exemption's approval.

(6)Upon issuing an exemption, the Department shall remind health care providers to

distribute, preferentially, influenza vaccines that are thimerosal-free or contain only trace amounts of thimerosal for the immunization of children under the age of 3, provided that the supply of influenza vaccines to health care providers is not impeded by the exercise of this preference.